MORTIMER IAN

CIK 00016199611 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001619961

Recent Transactions

50 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-01-09+65,000→ 65,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2026-01-09+350,000→ 350,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-01-02$7.49/sh+40,000→ 46,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2026-01-02−40,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-01-02$44.93/sh−2,062→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-01-02$44.40/sh−37,938→ 8,062 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-12-08$45.59/sh−8,820→ 8,010 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-12-08$46.32/sh−2,010→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-12-05$45.03/sh−14,375→ 16,830 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-11-28$45.01/sh−97→ 31,205 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-10-01$40.16/sh−25,000→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-10-01$7.69/sh+25,000→ 56,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-10-01−25,000→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-03-12+50,000→ 50,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-03-12+275,000→ 275,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$17.76/sh+15,166→ 46,468 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-01-27−16,315→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$17.76/sh+1,149→ 32,451 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$41.07/sh−1,149→ 31,302 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-27$40.46/sh−15,166→ 31,302 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-24$40.20/sh−22,468→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-24$17.76/sh+22,468→ 53,770 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-01-24−22,468→ 16,315 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-23$40.08/sh−16,217→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-01-23$17.76/sh+16,217→ 47,519 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-01-23−16,217→ 38,783 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-11+250,000→ 250,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$41.84/sh−3,902→ 40,887 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-05-24−6,172→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-05-24−20,576→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-05-24−42,592→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$41.49/sh−1,407→ 31,302 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$9.85/sh+20,576→ 44,789 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$9.44/sh+42,592→ 48,592 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$41.84/sh−7,310→ 41,282 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$41.44/sh−17,069→ 24,213 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$41.84/sh−1,171→ 32,709 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$9.85/sh+6,172→ 33,880 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-24$41.37/sh−13,179→ 27,708 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-10+380,000→ 380,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-10+400,000→ 400,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-06-03+125,000→ 125,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-03-12+100,000→ 100,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-03-12+145,000→ 145,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+135,000→ 135,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-03-12+105,000→ 105,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-10-23+25,000→ 25,000 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Stock
2017-08-10$2.90/sh+10,000→ 14,300 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Stock
2017-08-10$2.85/sh+5,000→ 6,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-03-13+75,000→ 75,000 total

Companies

Xenon Pharmaceuticals Inc.
Director, PRESIDENT & CEO
$XENE

Recent Filings

Address

3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov